Aims and Scope of Annals of Oncology

Annals of Oncology, the official journal of the European Society for Medical Oncology and the Japanese Society of Medical Oncology, is a renowned platform for rapid and efficient publication of innovative cancer treatments and translational work in oncology and precision medicine.

Key Areas of Focus

The journal’s primary areas of interest include:

• Systemic anticancer therapy, with a special emphasis on molecular targeted agents and novel immune therapies

While the journal’s primary focus is on systemic therapy, molecular targeted agents, and immune therapies, it also considers manuscripts on radiotherapy, surgery, and pediatrics if they demonstrate a clear interaction with one of the aforementioned areas or have the potential to be paradigm-shifting.

Editorial Board and Global Oncology Landscape

Annals of Oncology boasts an international editorial board comprising experts who are leaders in their fields. The journal’s mission is to provide the best possible communication on the rapidly evolving global oncology landscape, keeping pace with the latest developments and breakthroughs.

Recent Issues

Stay updated with the latest research and findings in oncology and precision medicine with our recent issues:

• Issue 12, December 2022, pp. 1209-1336
• Issue 11, November 2022, pp. 1091-1208
• Issue 10, October 2022, pp. 989-1090
• Issue 9, September 2022, pp. 855-988
• Issue 8, August 2022, pp. 745-854
• Issue 7, July 2022, pp. 669-744
• Issue 6, June 2022, pp. 569-668
• Issue 5, May 2022, pp. 457-568
• Issue 4, April 2022, pp. 357-456
• Issue 3, March 2022, pp. 231-356
• Issue 2, February 2022, pp. 119-230
• Issue 1, January 2022, pp. 1-118